Results 181 to 190 of about 5,761 (235)

Deep pelvic endometriosis: clinical features, diagnosis, and treatment - a comprehensive review. [PDF]

Arch Gynecol Obstet
Abike F, Tanoglu FB, Sidar G.
europepmc   +1 more source

Relugolix, Estradiol, and Norethindrone Acetate (Myfembree)

CDA-AMC
openalex   +2 more sources

Metabolomics analysis of gut metabolites in patients with colorectal polyps and in healthy individuals. [PDF]

Exp Ther Med
Deng D, Yao Y, Zhang H, Song H, Xia Y, Wang H, Zhao L, Guo Z, Jin Y.   +8 more
europepmc   +1 more source

The Pill: Abortifacient or Contraceptive?: A Literature Review [PDF]

, 1995
Tonti-Filippini, Nicholas
core   +1 more source

Pharmacovigilance insights into drug-associated venous thromboembolism. [PDF]

Int J Surg
Cai X, Chen G, Wang H, Wang L, Hu C.
europepmc   +1 more source

Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms. [PDF]

Drugs
Young Moss S, Lee A, Simon JA.
europepmc   +1 more source

Poliosis as a result of temporary eyelash tinting. [PDF]

JAAD Case Rep
Nusynowitz J, Matarasso SL.
europepmc   +1 more source

Testosterone treatment impacts the intestinal microbiome of transgender individuals. [PDF]

mSphere
Harris RM, Pace F, Kuntz TM, Morgan XC, Hyland P, Summers K, McDermott E, Blumen K, Watnick PI.   +8 more
europepmc   +1 more source

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61". [PDF]

Pharmaceuticals (Basel)
Tassi A, Londero AP, Xholli A, Lanzolla G, Bertozzi S, Savelli L, Prefumo F, Cagnacci A.   +7 more
europepmc   +1 more source